Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 651

1.
2.

Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre.

Chuansumrit A, Husapadol S, Wongwerawattanakoon P, Hongeng S, Sirachainan N, Pakakasama S.

Haemophilia. 2007 Jan;13(1):108-10.

PMID:
17212736
3.

Rituximab in the treatment of acquired factor VIII inhibitors.

Wiestner A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peerschke EI, Weksler BB, Schechter GP.

Blood. 2002 Nov 1;100(9):3426-8.

4.

Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.

Aleem A, Saidu A, Abdulkarim H, Al-Diab AR, Al-Sagheer A, Qayum A, Al-Momen AK.

Haemophilia. 2009 Jan;15(1):210-6. doi: 10.1111/j.1365-2516.2008.01865.x.

PMID:
19149851
5.

Successful rituximab therapy of acquired factor VIII inhibitor in a patient with rheumatoid arthritis.

Oliveira B, Arkfeld DG, Weitz IC, Shinada S, Ehresmann G.

J Clin Rheumatol. 2007 Apr;13(2):89-91.

PMID:
17414538
6.

Rituximab in the treatment of high responding inhibitors in severe haemophilia A.

Moschovi M, Aronis S, Trimis G, Platokouki H, Salavoura K, Tzortzatou-Stathopoulou F.

Haemophilia. 2006 Jan;12(1):95-9.

PMID:
16409183
7.

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

Stasi R, Brunetti M, Stipa E, Amadori S.

Blood. 2004 Jun 15;103(12):4424-8. Epub 2004 Mar 2.

8.

[Long-term response to rituximab in a patient with acquired hemophilia].

García-Chávez J, Vela-Ojeda J, García-Manzano A, Majluf-Cruz A.

Rev Invest Clin. 2011 Mar-Apr;63(2):210-2. Spanish.

PMID:
21717725
9.

Acquired haemophilia syndrome: pathophysiology and therapy.

Elezović I.

Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:64-8. Review.

10.

Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.

Huang YW, Saidi P, Philipp C.

Haemophilia. 2004 Nov;10(6):713-21.

PMID:
15569166
11.

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.

Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.

Rheumatology (Oxford). 2006 Nov;45(11):1432-6. Epub 2006 Apr 21.

PMID:
16632482
12.

[Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].

Dürig J, de Wit M, Fiedler W, Marx G, Hossfeld DK.

Schweiz Med Wochenschr. 1996 Nov 23;126(47):2026-31. German.

PMID:
8984611
14.

Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor.

Lian EC, Larcada AF, Chiu AY.

Ann Intern Med. 1989 May 15;110(10):774-8.

PMID:
2496636
15.

Rituximab alone or in association with corticosteroids in the treatment of acquired factor VIII inhibitors: report of two cases.

Berezné A, Stieltjes N, Le-Guern V, Teixeira L, Billy C, Roussel-Robert V, Flaujac C, Horellou MH, Guillevin L, Mouthon L.

Transfus Med. 2006 Jun;16(3):209-12.

PMID:
16764602
16.

Continuous infusion of porcine factor VIII in the management of patients with factor VIII inhibitors.

Rubinger M, Houston DS, Schwetz N, Woloschuk DM, Israels SJ, Johnston JB.

Am J Hematol. 1997 Oct;56(2):112-8.

17.

Successful treatment of acquired hemophilia with oral immunosuppressive therapy.

Shaffer LG, Phillips MD.

Ann Intern Med. 1997 Aug 1;127(3):206-9. Erratum in: Ann Intern Med 1998 Feb 15;128(4):330.

PMID:
9245226
18.

Acquired haemophilia: experiences with a standardized approach.

Grünewald M, Beneke H, Güthner C, Germowitz A, Brommer A, Griesshammer M.

Haemophilia. 2001 Mar;7(2):164-9.

PMID:
11260276
19.

Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience.

Carcao M, St Louis J, Poon MC, Grunebaum E, Lacroix S, Stain AM, Blanchette VS, Rivard GE; Inhibitor Subcommittee of Association of Hemophilia Clinic Directors of Canada.

Haemophilia. 2006 Jan;12(1):7-18.

PMID:
16409170
20.

Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.

Gringeri A, Musso R, Mazzucconi MG, Piseddu G, Schiavoni M, Pignoloni P, Mannucci PM; RITS-FITNHES Study Group.

Haemophilia. 2007 Jul;13(4):373-9.

PMID:
17610550

Supplemental Content

Support Center